CAS: 6205-08-9; (S)-2-Acetamido-5-Aminopentanoic Acid

相似化合物

2490-97-3 1946-82-3 58840-79-2

上下游产品

CAS号70-26-8 鸟氨酸

N'-Cbz-L-鸟氨酸置于10Percent Pd/c 氢气,碳酸氢钠体系中,用 甲醇 作为反应溶剂,化学反应生成 (S)-2-乙酰氨基-5-氨基戊酸
参考文献:Is N-Acetylornithine Aminotransferase The Real N-Succinyl-Ll-Diaminopimelate Aminotransferase In Escherichia Coli And Mycobacterium Smegmatis
标题:Is N-Acetylornithine Aminotransferase The Real N-Succinyl-Ll-Diaminopimelate Aminotransferase In Escherichia Coli And Mycobacterium Smegmatis
摘要:我们检查了大肠杆菌和耻垢分枝杆菌中的 N-琥珀酰-Ll-二氨基庚二酸转氨酶 (Dap-At) 和 N-乙酰鸟氨酸转氨酶 (Naco-At) 活性之间的异同,以调查最近关于这两种物质的说法.酶是同一种酶.结果不支持这两种活性由单一酶催化的假设.
DOI:10.1039/b106146C

专利信息

专利号:US-8497098-B2
优先权日:2004-07-15
标题 :Biochemical synthesis of 1,4-butanediamine
发明人：EPPELMANN KATRIN; NOSSIN PETRUS M M; RAEVEN LEON J R M; KREMER SUSANNE M; WUBBOLTS MARCEL G
权利人:EPPELMANN KATRIN; NOSSIN PETRUS M M; RAEVEN LEON J R M; KREMER SUSANNE M; WUBBOLTS MARCEL G; DSM IP ASSETS BV
摘要:The invention relates to a process for biochemical synthesis of 1,4-butanediamine in a microorganism having an increased level of an ornithine decarboxylase activity (increased ODC activity) as compared to the native level of the ornithine decarboxylase activity, wherein in the microorganism also an increased activity of N-acetylglutamate formation is present as compared to the native level of activity of N-acetylglutamate formation in the microorganism and wherein 1,4-butanediamine produced in the microorganism is excreted into a fermentation broth, and is recovered from the fermentation broth. The invention also relates to vectors, plasmids and hosts carrying a corresponding increased ODC activity and an increased activity of N-acetylglutamate formation.

专利号:US-2006269975-A1
优先权日:1999-07-16
标 题:Corynebacterium glutamicum genes encoding proteins involved in DNA replication, protein synthesis, and pathogenesis
发明人：POMPEJUS MARKUS; KROGER BURKHARD; SCHRODER HARTWIG; ZELDER OSKAR; HABERHAUER GREGOR
权利人:BASF AG
摘要:Isolated nucleic acid molecules, designated RRP nucleic acid molecules, which encode novel RRP proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing RRP nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated RRP proteins, mutated RRP proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of RRP genes in this organism.

专利号:US-2005244935-A1
优先权日:1999-06-25
标题:Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport
发明人：POMPEJUS MARKUS; KROGER BURKHARD; SCHRODER HARTWIG; ZELDER OSKAR; HABERHAUER GREGOR
权利人:BASF AG
摘要:Isolated nucleic acid molecules, designated MCT nucleic acid molecules, which encode novel MCT proteins from Corynebacterium glutamicum are described. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing MCT nucleic acid molecules, and host cells into which the expression vectors have been introduced. The invention still further provides isolated MCT proteins, mutated MCT proteins, fusion proteins, antigenic peptides and methods for the improvement of production of a desired compound from C. glutamicum based on genetic engineering of MCT genes in this organism.

专利号:US-2009011478-A1
优先权日:2004-07-15
标 题:Biochemical Synthesis of 1,4-Butanediamine

专利号:WO-2006005603-A1
优先权日:2004-07-15
标 题 :Biochemical synthesis of 1,4-butanediamine

专利号:US-10722441-B2
优先权日:2016-01-15
标题:Noreugenin glycoside derivatives
发明人：CAROLA CHRISTOPHE; SCHULTE MICHAEL; RABAUSCH ULRICH; ROSENFELD HENNING; STREIT WOLFGANG
权利人:UNIV HAMBURG
摘要:A use of noreugenin glycoside derivatives of formulas I, II and III as a self-tanning substance or to increase the synthesis of melanin, improve melanin transport and/or improve the distribution of melanin in suprabasal layers, preparations containing noreugenin glycoside derivatives of formulas I, II and III, and noreugenin glycoside derivatives of formulas I, II and III.